What is the recommended diagnostic approach for evaluating a patient with suspected hypertension?

Diagnostic Approach to Hypertension

The diagnosis of hypertension should be confirmed using out-of-office blood pressure monitoring (ambulatory or home monitoring) whenever feasible, following initial elevated office readings, with diagnosis based on specific thresholds that vary by measurement method and patient risk factors.

Initial Office Visit and Blood Pressure Measurement

When a patient presents with elevated blood pressure (≥140/90 mmHg), schedule a dedicated hypertension assessment visit 1, 2. At this initial visit:

• Take at least 3 readings using a validated automated oscillometric device, discard the first, and average the last two 1, 2
• Conduct focused history examining: cardiovascular risk factors (diabetes, smoking, dyslipidemia, family history of premature CVD), symptoms of secondary hypertension, and medications/substances that elevate BP (NSAIDs, corticosteroids, oral contraceptives, decongestants) 3, 4
• Perform physical examination looking for: signs of target organ damage (retinopathy, cardiac abnormalities, peripheral pulses), features suggesting secondary causes (abdominal bruits for renal artery stenosis, delayed femoral pulses for coarctation) 3

Diagnostic Thresholds by Visit and Risk Status

The diagnostic pathway differs based on the severity of initial readings and presence of high-risk conditions:

Visit 1 - Immediate Diagnosis Criteria:

• SBP ≥180 mmHg and/or DBP ≥110 mmHg: Diagnose hypertension immediately (exclude hypertensive emergency first) 1, 5
• Hypertensive emergency features: Diagnose and treat immediately 1

Visit 2 (within 1 month) - Risk-Stratified Diagnosis:

High-risk patients (diabetes, chronic kidney disease with eGFR <60 mL/min/1.73m², or macrovascular target organ damage):

• Diagnose hypertension if SBP ≥140 mmHg and/or DBP ≥90 mmHg 1, 6

Lower-risk patients (no diabetes, CKD, or target organ damage):

• Diagnose immediately if SBP ≥180 mmHg and/or DBP ≥110 mmHg 1
• For lower readings (140-179/90-109 mmHg), proceed to out-of-office monitoring before diagnosis 1, 5

Out-of-Office Blood Pressure Monitoring (Preferred Diagnostic Method)

Ambulatory BP monitoring (ABPM) is the gold standard for confirming hypertension after initial elevated office readings 1, 7, 8. It provides superior prognostic accuracy compared to office measurements and identifies white coat hypertension.

ABPM Diagnostic Thresholds:

• Mean 24-hour: ≥130/80 mmHg, OR
• Mean awake: ≥135/85 mmHg 1, 6

Home BP Monitoring (HBPM) - Alternative if ABPM unavailable:

• Measure duplicate readings, morning and evening, for 7 days (discard first day) 1
• Diagnose hypertension if average ≥135/85 mmHg 1, 6
• If home readings <135/85 mmHg, confirm white coat hypertension with ABPM showing mean 24-hour <130/80 mmHg 1

Office-Only Diagnosis (if out-of-office monitoring not feasible):

• 3 visits: Average SBP ≥160 mmHg or DBP ≥100 mmHg, OR
• 5 visits: Average SBP ≥140 mmHg or DBP ≥90 mmHg 1, 6

Essential Baseline Laboratory and Diagnostic Testing

Within the first 2 visits, obtain these tests to assess cardiovascular risk, target organ damage, and secondary causes 3, 2:

Mandatory Laboratory Tests:

• Serum creatinine and eGFR (assess kidney function)
• Urine albumin-to-creatinine ratio (detect early kidney damage) 2
• Fasting glucose or HbA1c (screen for diabetes)
• Lipid profile (LDL-C, HDL-C, triglycerides)
• Serum electrolytes (potassium, sodium)
• 12-lead ECG (detect left ventricular hypertrophy, atrial fibrillation, ischemic changes) 3

Additional Testing When Indicated:

• Serum uric acid (common in hypertension, guides treatment) 3
• Aldosterone-renin ratio if features suggest primary aldosteronism (hypokalemia, resistant hypertension) 3, 2
• Echocardiography if ECG abnormalities, symptoms of heart failure, or when LVH detection would influence treatment 3, 5
• Renal ultrasound/imaging if suspected renovascular disease or renal parenchymal disease 3

Screening for Secondary Hypertension

Investigate secondary causes when clinical features suggest 3, 4:

• Age <30 years with hypertension
• Resistant hypertension (uncontrolled on 3+ drugs including diuretic)
• Sudden onset or worsening of previously controlled hypertension
• Hypokalemia (unprovoked or diuretic-induced)
• Abdominal bruit (renovascular disease)
• Features of Cushing syndrome or pheochromocytoma

Specific tests include: aldosterone-renin ratio, plasma metanephrines, late-night salivary cortisol, renal artery imaging 3.

Cardiovascular Risk Assessment

All hypertensive patients require cardiovascular risk stratification to guide treatment intensity 3, 2:

• Use SCORE2 (ages 40-69) or SCORE2-OP (≥70 years) in appropriate populations 5
• In the US, use PREVENT equations (race-free) with 7.5% 10-year risk threshold for stage 1 hypertension treatment 2, 9
• Assess for: age >65 years, male sex, smoking, diabetes, dyslipidemia, family history of premature CVD, obesity 3

Common Pitfalls to Avoid

• Do not diagnose based on single office visit unless BP ≥180/110 mmHg or hypertensive emergency 1, 5
• Do not miss white coat hypertension: 15-30% of patients with elevated office BP have normal out-of-office readings 1, 7
• Do not use unvalidated BP devices: Only use devices meeting AAMI, BHS, or International Protocol standards 1, 2
• Do not overlook exogenous causes: NSAIDs, decongestants, and oral contraceptives commonly elevate BP 4
• Do not delay Visit 2 beyond 1 month unless BP <140/90 mmHg 1

Follow-up for Non-Hypertensive Patients

If not diagnosed with hypertension after evaluation:

• Annual BP assessment if no target organ damage 1, 6
• More frequent monitoring if high-normal BP (130-139/85-89 mmHg) 10